Updates on Yaz & Yasmin Lawsuits

The German pharmaceutical company, Bayer Healthcare, introduced the birth control formulation Yasmin in 2001 and Yaz in 2006. The combination oral contraceptives contain estrogen and progestin, also known as drospirenone, which prevent ovulation and the possibility of pregnancy. Both preparations were marketed heavily with promises that the drugs were safe and created minimal PMS symptoms of acne and bloating. Since their introduction to the general public, approximately 100 million women began prescriptions of the formulations.

FDA Reports

However, the FDA and other medication regulatory agencies worldwide began receiving reports of serious adverse reactions associated with the medications that included an increased risk of developing blood clots in the form of deep vein thrombosis or pulmonary embolism. The blood clots that women developed also led to heart attacks and strokes.

In 2011, the British Medical Journal published research performed at the University of Copenhagen. The study confirmed that the form of progestin used in Yaz increased the risk of blood clots. The FDA performed another study that evaluated the health of more than 800,000 women and found that drospirenone-containing formulas increased the risk of blood clot and related medical conditions by up to 74%. By 2012, the Institute for Safe Medicine Practices indicated that Yasmin and Yaz were the second-highest ranking medications to produce complications.

Lawsuits Begin

By 2012, Bayer Healthcare was named in more than 13,000 Yasmin and Yaz lawsuits for failure to fully disclose the possible life-threatening risks. According to the Bayer company’s recent financial reports, the corporation spent approximately $1.575 billion dollars to settle almost 7,660 claims. The average amount paid per claim was documented as being around $212,000. Settlements remain pending, and the company has additional funds set aside to compensate victims of the preparations. The latest court documents indicate that the number of cases pending against Bayer dropped in February to 9,687. The number of cases recorded for the previous month totaled 9,781.

In Illinois, the number of women filing a Yaz lawsuit made it necessary to consolidate the cases into a special federal Multi-District Litigation court. Unlike a class-action lawsuit, the claims are handled on an individual basis, which has resulted in higher compensatory amounts. Victims additionally have the option of choosing legal counsel.

Medication Updates

DrugRisk.com recently announced that the site featured updated information concerning the birth control formulas. The resource offers litigation updates, product recalls, safety alerts and the latest news concerning Yaz, Yasmin and other medications. Information comes from the FDA, the British Medical Journal and the Medicines and Healthcare Products Regulatory Agency of Great Britain. Visitors may also learn about side effects and the potential dangers of taking pharmaceuticals to help determine the need to seek legal assistance.

Sources
http://www.drugrisk.com/yaz
http://www.drugnews.net/yaz/lawsuit